UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Haematologica (Roma), 2015-05, Vol.100 (5), p.670

2015

Link zum Volltext

Verfügbarkeit prüfen

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

The lancet oncology, 2018-04, Vol.19 (4), p.486-496

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

British journal of haematology, 2020-02, Vol.188 (3), p.404-412

2020

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1156-e111

2017

Link zum Volltext

Verfügbarkeit prüfen

Self-reported adherence to lenalidomide as maintenance therpay for multiple myeloma after autologous stem cell transplantation

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e20046-e20046

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

Gynecologic oncology, 2004-12, Vol.95 (3), p.506-512

2004

Link zum Volltext

Verfügbarkeit prüfen

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS8063-TPS8063

2023

Link zum Volltext

Verfügbarkeit prüfen

Outreach: Preliminary safety and efficacy results from a phase 2 study of lisocabtagene maraleucel (liso-cel) in the nonuniversity setting

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19513-e19513

2021

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7533-7533

2018

Link zum Volltext

Verfügbarkeit prüfen

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

American journal of clinical pathology, 1991-12, Vol.96 (6), p.738-745

1991

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts

Blood, 2015-12, Vol.126 (23), p.1825-1825

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.8513-8513

2015

Link zum Volltext

Verfügbarkeit prüfen

DUO: A phase 3 trial of the PI3K-δ,γ inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS7122-TPS7122

2014

Link zum Volltext

Verfügbarkeit prüfen

DYNAMO: A phase 2 trial of the PI3K-δ,γ inhibitor IPI-145 in patients with refractory indolent non-Hodgkin lymphoma

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS8619-TPS8619

2014

Link zum Volltext

Verfügbarkeit prüfen

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease

Biology of blood and marrow transplantation, 2005-03, Vol.11 (3), p.188-193

2005

Link zum Volltext

Verfügbarkeit prüfen

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

Annals of internal medicine, 1998-06, Vol.128 (12 Pt 1), p.975

1998

Link zum Volltext

Verfügbarkeit prüfen

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S187-S188

2020

Link zum Volltext

Verfügbarkeit prüfen

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Biology of blood and marrow transplantation, 2019-03, Vol.25 (3), p.S28-S29

2019

Link zum Volltext

Verfügbarkeit prüfen

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S70

2018

Link zum Volltext

Verfügbarkeit prüfen

38 - Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S70-S70

2018

Link zum Volltext

Verfügbarkeit prüfen

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996, Vol.78 (10), p.1161-1163

1996

Link zum Volltext

Verfügbarkeit prüfen

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Journal of cardiothoracic and vascular anesthesia, 1993, Vol.7 (4), p.410-415

1993

Link zum Volltext

Verfügbarkeit prüfen

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Blood, 1992-05, Vol.79 (10), p.2784-2788

1992

Link zum Volltext

Verfügbarkeit prüfen

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

The American journal of cardiology, 1996-11, Vol.78 (10), p.1161-1163

1996

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial Evaluating the Safety of Rapid Infusion Ofatumumab (OFA) in Patients (pts) with Previously Treated Chronic Lymphocytic Leukemia (CLL)

Blood, 2014-12, Vol.124 (21), p.3336-3336

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Adult
(6)
Female
(6)
Middle Aged
(6)
Biological And Medical Sciences
(5)
Male
(5)
Medical Sciences
(5)
Aged
(4)
Aged, 80 And Over
(3)
Hematology
(3)
Oncology
(3)
Pharmacology. Drug Treatments
(3)
Busulfan - Therapeutic Use
(2)
Cyclophosphamide - Therapeutic Use
(2)
Graft Vs Host Disease - Prevention & Control
(2)
Lymphoma
(2)
Patients
(2)
Platelet Count
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

Self-reported adherence to lenalidomide as maintenance therpay for multiple myeloma after autologous stem cell transplantation

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory multiple myeloma (CAMMOUFLAGE trial)

Outreach: Preliminary safety and efficacy results from a phase 2 study of lisocabtagene maraleucel (liso-cel) in the nonuniversity setting

The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues

A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts

A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM)

DUO: A phase 3 trial of the PI3K-δ,γ inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

DYNAMO: A phase 2 trial of the PI3K-δ,γ inhibitor IPI-145 in patients with refractory indolent non-Hodgkin lymphoma

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

KD025 for Patients with Chronic Graft-Versus-Host Disease (cGVHD) – Long-Term Follow-up of a Phase 2a Study (KD025-208)

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) - Pharmacodynamics (PD) and Updated Results

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

38 - Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

Marked Increase in Veno-Occlusive Disease of the Liver Associated With Methotrexate Use for Graft-Versus-Host Disease Prophylaxis in Patients Receiving Busulfan/Cyclophosphamide

Abciximab-associated profound thrombocytopenia : Therapy with immunoglobulin and platelet transfusion

A Phase II Trial Evaluating the Safety of Rapid Infusion Ofatumumab (OFA) in Patients (pts) with Previously Treated Chronic Lymphocytic Leukemia (CLL)

Suchergebnisse filtern